Market Overview:
The global amifostine market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of head and neck cancer, rising demand for adjuvant therapy, and growing awareness about amifostine. The global amifostine market is segmented on the basis of type and application. On the basis of type, the market is segmented into 400mg/dose and 500mg/dose. On the basis of application, the market is segmented into head and neck cancer adjuvant therapy and others. The others segment includes esophageal cancer, ovarian cancer, bladder cancer, cervical cancer among others. Geographically, North America dominates the global amifostine market followed by Europe due to early adoption of new technologies in these regions coupled with rising incidence rates for head and neck cancers in these regions.
Product Definition:
A drug used to protect the kidneys from radiation damage. Amifostine (Ethyol) is given by vein before radiation therapy begins. It enters the blood and travels to the kidneys, where it helps protect them from damage.
400mg/Dose:
400 mg/dose is a prescription medicine used for the treatment of patients with advanced melanoma. It is also used in combination with radiation therapy and surgery. 400mg/dose amifostine has been studied to show positive results in prolonging overall survival time among patients diagnosed with metastatic melanoma, especially when 400 mg/day amifostine is administered along with standard chemotherapeutic drugs.
Amifostine was approved by the U.
500mg/Dose:
500mg/Dose is a prescription medicine used for the treatment of patients with HIV-1 infection. It is also used in combination therapy with other antiretrovirals to treat HIV-1 infected patients. 500 mg single dose ampoules and bottles containing 100 mg are approved by the U.S Food and Drug Administration (FDA) for sale in the U.
Application Insights:
Head and neck cancer adjuvant therapy was the largest application segment in 2017. Amifostine is used as an adjunct to radiotherapy in the treatment of head and neck cancers, which has resulted in its becoming one of the most popularly prescribed drugs across various regions. The others segment includes use amifostine for Parkinson¢â‚¬â„¢s disease, multiple sclerosis, rheumatoid arthritis and other conditions where inflammation is a prominent feature.
The demand for amifostine from head and neck cancer patients is expected to increase significantly owing to increasing awareness about advanced therapies with better efficacy coupled with reduced toxicity compared to conventional ones. This factor will result in market growth over the forecast period on account of increasing applications within this sector during future years.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing cases of head and neck cancer, rising healthcare expenditure, and growing awareness about amifostine treatment. In addition, supportive government initiatives are also anticipated to propel product demand in North America during the forecast period.
Asia Pacific is estimated to be one of the fastest-growing regions over the coming years due to improving economic conditions in emerging countries such as China and India that have a high prevalence rate for cancer types including head and neck cancers. Moreover, these countries offer tremendous growth opportunities for oncology drug manufacturers due to rapidly expanding markets with high unmet clinical needs that can be addressed by amifostine therapy (Topical). ‰vitamins A & E may help reduce skin dryness caused by this medication.- Vitamin C helps increase resistance against infections.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for the amifostine market. According to a study by the World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from cancer worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will create a large demand for amifostine, as it is used in the treatment of various types of cancers.
- Rising awareness about chemotherapy-induced toxicity: Chemotherapy-induced toxicity is another major growth driver for the amifostine market. Amifostine helps reduce chemotherapy-induced toxicity, which has resulted in an increase in its demand over the past few years.
- Growing use of radiation therapy: The growing use of radiation therapy is also contributing to the growth of the amifostine market globally . Radiation therapy uses high energy X-rays or other typesof radiation beams to kill or shrink tumors . Itis increasingly being used as an alternative or adjunct totreatment options such as surgery and chemotherapy , due tobetter outcomes and fewer side effects compared with traditionaltreatment methods . Amifostine helps protect healthy tissues from damage causedby radiation therapy, thereby improving patient outcomes .
- . Technological advancements: The developmentof novel technologies that can improve patient outcomes whilereducing side effects associated with radiotherapy are aidingthe growth o ftheam if ost
Scope Of The Report
Report Attributes
Report Details
Report Title
Amifostine Market Research Report
By Type
400mg/Dose, 500mg/Dose
By Application
Head and Neck Cancer Adjuvant Therapy, Others
By Companies
Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Amifostine Market Report Segments:
The global Amifostine market is segmented on the basis of:
Types
400mg/Dose, 500mg/Dose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Head and Neck Cancer Adjuvant Therapy, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Clinigen
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
Highlights of The Amifostine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 400mg/Dose
- 500mg/Dose
- By Application:
- Head and Neck Cancer Adjuvant Therapy
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amifostine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amifostine is a medication used to treat cancer. It works by stopping the growth of cancer cells.
Some of the major companies in the amifostine market are Clinigen, Sun Pharmaceutical, Taj Pharmaceuticals, Merro Pharmaceutical, Luye Pharma, Mingren Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amifostine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amifostine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amifostine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amifostine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amifostine Market Size & Forecast, 2020-2028
4.5.1 Amifostine Market Size and Y-o-Y Growth
4.5.2 Amifostine Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 400mg/Dose
5.2.2 500mg/Dose
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Head and Neck Cancer Adjuvant Therapy
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amifostine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amifostine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 400mg/Dose
9.6.2 500mg/Dose
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Head and Neck Cancer Adjuvant Therapy
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 400mg/Dose
10.6.2 500mg/Dose
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Head and Neck Cancer Adjuvant Therapy
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 400mg/Dose
11.6.2 500mg/Dose
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Head and Neck Cancer Adjuvant Therapy
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 400mg/Dose
12.6.2 500mg/Dose
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Head and Neck Cancer Adjuvant Therapy
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 400mg/Dose
13.6.2 500mg/Dose
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Head and Neck Cancer Adjuvant Therapy
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amifostine Market: Competitive Dashboard
14.2 Global Amifostine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Clinigen
14.3.2 Sun Pharmaceutical
14.3.3 Taj Pharmaceuticals
14.3.4 Merro Pharmaceutical
14.3.5 Luye Pharma
14.3.6 Mingren Pharma
